Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |